xarelto

Generic: rivaroxaban

Labeler: janssen pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name xarelto
Generic Name rivaroxaban
Labeler janssen pharmaceuticals, inc.
Dosage Form GRANULE, FOR SUSPENSION
Routes
ORAL
Active Ingredients

rivaroxaban 155 mg/1

Manufacturer
Janssen Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 50458-575
Product ID 50458-575_48884709-657d-6712-e063-6394a90a88e7
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA215859
Listing Expiration 2027-12-31
Marketing Start 2021-12-01

Pharmacologic Class

Established (EPC)
factor xa inhibitor [epc]
Mechanism of Action
factor xa inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50458575
Hyphenated Format 50458-575

Supplemental Identifiers

RxCUI
1114198 1114202 1232082 1232084 1232086 1232088 1549682 1549683 2059015 2059017 2588062 2588066
UPC
0350458575019 0350458579307 0350458580303 0350458578300 0350458577600
UNII
9NDF7JZ4M3
NUI
N0000175635 N0000175637

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name xarelto (source: ndc)
Generic Name rivaroxaban (source: ndc)
Application Number NDA215859 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 155 mg/1
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE
source: ndc

Packages (1)

50458-575-01 1 BOTTLE in 1 CARTON (50458-575-01) / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE

Ingredients (1)

rivaroxaban (155 mg/1)

Linked Drug Pages (1)

Xarelto, XARELTO ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48884709-657d-6712-e063-6394a90a88e7", "openfda": {"nui": ["N0000175635", "N0000175637"], "upc": ["0350458575019", "0350458579307", "0350458580303", "0350458578300", "0350458577600"], "unii": ["9NDF7JZ4M3"], "rxcui": ["1114198", "1114202", "1232082", "1232084", "1232086", "1232088", "1549682", "1549683", "2059015", "2059017", "2588062", "2588066"], "spl_set_id": ["10db92f9-2300-4a80-836b-673e1ae91610"], "pharm_class_epc": ["Factor Xa Inhibitor [EPC]"], "pharm_class_moa": ["Factor Xa Inhibitors [MoA]"], "manufacturer_name": ["Janssen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (50458-575-01)  / 1 GRANULE, FOR SUSPENSION in 1 BOTTLE", "package_ndc": "50458-575-01", "marketing_start_date": "20211201"}], "brand_name": "Xarelto", "product_id": "50458-575_48884709-657d-6712-e063-6394a90a88e7", "dosage_form": "GRANULE, FOR SUSPENSION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "50458-575", "generic_name": "rivaroxaban", "labeler_name": "Janssen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Xarelto", "active_ingredients": [{"name": "RIVAROXABAN", "strength": "155 mg/1"}], "application_number": "NDA215859", "marketing_category": "NDA", "marketing_start_date": "20211201", "listing_expiration_date": "20271231"}